Early
aggressive chemotherapy therapy controls
micrometastases, reduces
tumor bulk and allows
for more limited procedures for local
control
Combination
chemotherapy with Adriamycin-based regimens
are commonly used. Tumor response rates are
seen in 80% of patients. About 10% of patients
will have a complete response with chemotherapy.
While
in some respects there is little a patient
can do to improve their outcome besides
endure treatment, it turns out that the
time
of day at which chemotherapy is administered
appears to be an important factor in optimizing
long term outcome. This is because cancer
cells and normal body cells have different
cycles of division and resting. Get
your Adriamycin at 5 am and your body
cells will get less impact than the cancer
cells.
Click
here to visit the chemotherapy module.
